Overview
Helen Collins is an Oncologist in Foster City, California. Her top areas of expertise are Myelofibrosis, Chronic Myelogenous Leukemia (CML), and Lung Cancer.
Her clinical research consists of co-authoring 9 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
Locations
333 Lakeside Dr, Foster City, CA 94404
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Stanford University
Ranjana Advani is an Oncologist in Palo Alto, California. Dr. Advani has been practicing medicine for over 44 years is highly rated in 29 conditions, according to our data. Her top areas of expertise are Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Transplant, and Tissue Biopsy.
Stanford University
Heather Wakelee is an Oncologist in Palo Alto, California. Dr. Wakelee is highly rated in 16 conditions, according to our data. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Thymic Epithelial Tumor, Thymectomy, and Tissue Biopsy.
Gynecology Clinic In Palo Alto
Kristen Ganjoo is an Oncologist in Palo Alto, California. Dr. Ganjoo is highly rated in 34 conditions, according to our data. Her top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Synovial Sarcoma, Gastrointestinal Stromal Tumor, and Pancreaticoduodenectomy.
Frequently Asked Questions about Dr. Helen Collins
How do I make an appointment with Dr. Helen Collins?
You can book an appointment with Dr. Helen Collins by calling their office at 800-445-3235. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Helen Collins a top-rated expert for Myelofibrosis?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Helen Collins is classified as an Experienced expert for Myelofibrosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Helen Collins specialize in?
While Dr. Helen Collins is a Oncology, they have specific expertise in Myelofibrosis, Chronic Myelogenous Leukemia (CML), and Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Helen Collins participate in research or clinical trials?
Yes. Dr. Helen Collins has published 9 articles and abstracts on conditions like Myelofibrosis. You can view a list of Dr. Helen Collins's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Helen Collins accept my insurance?
Dr. Helen Collins accepts most major insurance plans, including Cigna and Medicaid. We recommend calling the office directly at 800-445-3235 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Chronic Myelogenous Leukemia (CML)Dr. Collins isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Lung CancerDr. Collins isExperienced. Learn about Lung Cancer.
- MyelofibrosisDr. Collins isExperienced. Learn about Myelofibrosis.